The results of the GSEA also confirmed that cellular glucose metabolism was significantly enriched in endometrial cancer patients with POLE mutations, suggesting a possible approach to improving the prognosis of endometrial cancer through POLE mutation. The gene discussed is POLE; the disease is endometrial cancer.